BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10228065)

  • 1. Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide.
    Hutchins WA; Carlone GM; Westerink MA
    J Infect Dis; 1999 Jun; 179(6):1433-40. PubMed ID: 10228065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
    Prinz DM; Smithson SL; Westerink MA
    J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. I. Ontogeny.
    Rubinstein LJ; Stein KE
    J Immunol; 1988 Dec; 141(12):4352-6. PubMed ID: 3143762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine development.
    Colino J; Outschoorn I
    J Infect Dis; 2001 Dec; 184(12):1538-47. PubMed ID: 11740729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotype concentrations of human antibodies to group A meningococcal polysaccharide.
    Rautonen N; Pelkonen J; Sipinen S; Käyhty H; Mäkelä O
    J Immunol; 1986 Oct; 137(8):2670-5. PubMed ID: 3093581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
    Rubinstein LJ; Stein KE
    J Immunol; 1988 Dec; 141(12):4357-62. PubMed ID: 3143763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
    Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.
    García-Ojeda PA; Monser ME; Rubinstein LJ; Jennings HJ; Stein KE
    Infect Immun; 2000 Jan; 68(1):239-46. PubMed ID: 10603394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immune response to a peptide mimic of Neisseria meningitidis serogroup C in hu-PBMC-SCID mice.
    Hutchins WA; Kieber-Emmons T; Carlone GM; Westerink MA
    Hybridoma; 1999 Apr; 18(2):121-9. PubMed ID: 10380011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
    Carmenate T; Guirola M; Alvarez A; Canaán L; González S; Caballero E; Menéndez T; Guillén G
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):133-40. PubMed ID: 15681142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential use of lambda light chains is associated with defective mouse antibody responses to the capsular polysaccharide of Neisseria meningitidis group B.
    Colino J; Outschoorn I
    Immunobiology; 2004; 209(3):265-76. PubMed ID: 15518338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative ELISA for antigen-specific IgG subclasses using equivalence dilutions of anti-kappa and anti-subclass specific secondary reagents. Application to the study of the murine immune response against the capsular polysaccharide of Neisseria meningitidis serogroup B.
    Colino J; Diez M; Outschoorn I
    J Immunol Methods; 1996 Apr; 190(2):221-34. PubMed ID: 8621957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
    de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
    Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
    Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
    J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to study variable heavy chain gene usage in response to the capsular polysaccharide of Neisseria meningitidis serogroup C.
    Srivastava N; Smithson SL; Westerink MA
    J Microbiol Methods; 2002 Aug; 50(3):249-62. PubMed ID: 12031575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the heavy chain of antibodies that recognize the capsular polysaccharide of Neisseria meningitidis in hu-PBMC reconstituted SCID mice and in the immunized human donor.
    Smithson SL; Srivastava N; Hutchins WA; Westerink MA
    Mol Immunol; 1999 Feb; 36(2):113-24. PubMed ID: 10378683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
    Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
    Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human immune response to Neisseria meningitidis serogroup C in interleukin-12-treated severe combined immunodeficient mice engrafted with human peripheral blood lymphocytes.
    Westerink MA; Metzger DW; Hutchins WA; Adkins AR; Holder PF; Pais LB; Gheesling LL; Carlone GM
    J Infect Dis; 1997 Jan; 175(1):84-90. PubMed ID: 8985200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.